OppenheimerFunds’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

OppenheimerFunds’s Portfolio MR Stock Details MR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-373,690	Closed	-$10.2M	–	996
2015 Q1	$10.2M	Sell	373,690 -25,810	-6%	-$711K	0.01%	751
2014 Q4	$10.5M	Sell	399,500 -6,449,704	-94%	-$189M	0.01%	746
2014 Q3	$207M	Sell	6,849,204 -359,830	-5%	-$11.1M	0.23%	127
2014 Q2	$227M	Buy	7,209,034 +1,549,850	+27%	+$49.2M	0.25%	106
2014 Q1	$183M	Buy	5,659,184 +5,270,934	+1,358%	+$185M	0.22%	129
2013 Q4	$14.1M	Buy	+388,250	New	+$15.1M	0.02%	658

Other funds holding MR

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

GAM

Genesis Asset Managers Guernsey, Channel Islands, United Kingdom $3.53B AUM 1.54% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

CCMH

Cornerstone Capital Management Holdings New York $14.3B AUM 33.3% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

OppenheimerFunds's MR Position: Q2 2015 in Review

OppenheimerFunds sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q2 2015, closing a stake of 373,690 shares — an estimated $10.2M sold.

OppenheimerFunds first reported a position in MR in Q4 2013 and held it in 6 quarters. The position peaked at $227M in Q2 2014. 118 funds tracked by Wall St. Rank hold MR as of Q2 2015.

OppenheimerFunds reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q2 2015 after selling out during the quarter.
OppenheimerFunds sold 373,690 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q2 2015, an estimated $10.2M.
OppenheimerFunds first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q4 2013 and held it in 6 quarters.
OppenheimerFunds's MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $227M in Q2 2014.
118 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q2 2015.

Based on OppenheimerFunds's 13F filing for Q2 2015, filed 6 Aug 2015.